NXGL
NXGL
NASDAQ · Health Care

Nexgel Inc

$0.63
+0.03 (+4.20%)
Financial Highlights (FY 2026)
Revenue
14.62M
Net Income
-5,523,476
Gross Margin
31.6%
Profit Margin
-37.8%
Rev Growth
+77.6%
D/E Ratio
0.18
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.6% 31.6% 62.3% 62.3%
Operating Margin -40.9% -36.8% 15.0% 15.7%
Profit Margin -37.8% -35.9% 11.4% 15.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 14.62M 8.23M 5.33M 4.69M
Gross Profit 4.63M 2.60M 3.32M 2.92M
Operating Income -5,982,993 -3,031,239 798.7K 735.9K
Net Income -5,523,476 -2,798,428 604.4K 705.4K
Gross Margin 31.6% 31.6% 62.3% 62.3%
Operating Margin -40.9% -36.8% 15.0% 15.7%
Profit Margin -37.8% -35.9% 11.4% 15.0%
Rev Growth +77.6% +77.6% +6.5% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 579.8K 579.8K 6.23M 5.69M
Total Equity 3.18M 3.18M 8.36M 7.17M
D/E Ratio 0.18 0.18 0.75 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,514,707 -2,949,207 1.03M 893.3K
Free Cash Flow 660.3K 478.5K